1. Protein Tyrosine Kinase/RTK Autophagy
  2. Anaplastic lymphoma kinase (ALK) c-Met/HGFR ROS Kinase Autophagy
  3. Crizotinib hydrochloride

Crizotinib hydrochloride  (Synonyms: PF-02341066 hydrochloride)

目录号: HY-50878A 纯度: 99.72%
COA 产品使用指南 技术支持

Crizotinib hydrochloride (PF-02341066 hydrochloride) 是一种口服生物可用的,具有选择性的 ATP 竞争性双 ALKc-Met 抑制剂,IC50 分别为 20 和 8 nM。在细胞的实验中,Crizotinib hydrochloride (PF-02341066 hydrochloride) 抑制 NPM-ALK 的酪氨酸磷酸化和 c-Met 的酪氨酸磷酸化,IC50 分别为 24 和 11 nM。它也是 ROS 原癌基因 1 (ROS1) 抑制剂。Crizotinib hydrochloride (PF-02341066 hydrochloride) 具有有效的肿瘤生长抑制作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Crizotinib hydrochloride Chemical Structure

Crizotinib hydrochloride Chemical Structure

CAS No. : 1415560-69-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥397
In-stock
5 mg ¥371
In-stock
10 mg ¥590
In-stock
25 mg ¥854
In-stock
50 mg ¥1196
In-stock
100 mg ¥1680
In-stock
200 mg ¥2100
In-stock
500 mg ¥2900
In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Crizotinib hydrochloride:

MCE 顾客使用本产品发表的 68 篇科研文献

WB

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Evid Based Complement Alternat Med. 2019 Nov 7;2019:4253846.  [Abstract]

    Western blot analysis of cleaved caspase 3, Bax, and Bcl-2 expression after serum-free culture for 72 h with or without Crizotinib.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: J Hematol Oncol. 2018 Aug 29;11(1):109.  [Abstract]

    Resistant cells are treated with 200 nM Afatinib alone or in combination with 1 μM Crizotinib for 48 h.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Cancer Lett. 2018 May 28;422:19-28.  [Abstract]

    CD74-ROS1 or CD74-ROS1 G2032R mutation cells are treated with Crizotinib for 24 h, the expression of ROS1 or p-ROS1 is determined by western blot.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Mol Oncol. 2017 Aug;11(8):996-1006.  [Abstract]

    Dose-response and time course comparison of ALK inhibition by Crizotinib or Ceritinib.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Dis Model Mech. 2016 Sep 1;9(9):941-52.  [Abstract]

    CLB-BAR, CLB-GE neuroblastoma cells are treated for 6 h with either Crizotinib or PF-04643922. Cells are harvested and pre-cleared cell lysates are analyzed on SDS PAGE followed by western blotting for ALK, phospho-ALK-Y1278, phospho-ERK5, pan-ERK5 phospho-ERK1/2 and pan-ERK. Actin is employed as a loading control. Protein band intensities are quantified by Image Studio Lite 3.1 and normalized to untreated samples.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Oncotarget. 2016 May 17;7(20):29011-22.  [Abstract]

    A, B. CLB-BAR (ALK-Δ4-11) and CLB-GE (ALK-F1174V), both ALK addicted cell lines, are treated with increasing doses of Brigatinib for 6 hours. Crizotinib (250 nM) is employed as a positive control. Cells lysates are resolved on SDS/PAGE followed by immunoblotting for pALK (Y1604) and additional downstream targets as indicated.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Sci Signal. 2014 Oct 28;7(349):ra102.  [Abstract]

    Activation of ERK5 in neuroblastoma cell lines expressing activated ALK. (A to C) Immunoblotting for the indicated proteins in neuroblastoma cells CLB-BAR (A), CLB-GE (B), and IMR32 (C) cultured on six-well plates in complete growth medium and treated with inhibitors as indicated for 6 hours alone (A and B) or before (C) stimulation with mAb46 for 30 min.

    Crizotinib hydrochloride purchased from MCE. Usage Cited in: Oncotarget. 2014 May 15;5(9):2688-702.  [Abstract]

    The Ret expression level is investigated by Western blot in MYCN/KI AlkR1279Q and MYCN/KI AlkF1178L treated tumors and controls using the anti-Ret antibody EPR2871. Actin is used as a standard for quantification.
    • 生物活性

    • 实验参考方法

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. It is also a ROS proto-oncogene 1 (ROS1) inhibitor. Crizotinib hydrochloride (PF-02341066 hydrochloride) has effective tumor growth inhibition[1][2][3].

    IC50 & Target

    IC50: 20 nM (ALK), 8 nM (c-Met)[3]

    体外研究
    (In Vitro)

    PF-2341066 对 mIMCD3 小鼠或 MDCK 犬上皮细胞中的 c-Met 磷酸化表现出相似的效力,IC50 分别为 5 nM 和 20 nM。与表达野生型受体的 NIH3T3 细胞 (IC50 为 13 nM) 相比,PF-2341066 对表达 c-Met ATP 结合位点突变体 V1092I 或 H1094R 或 P 环突变体 M1250T 的 NIH3T3 细胞表现出增强或相似的活性(IC50 分别为 19 nM、2 nM 和 15 nM)。相反,与野生型受体相比,PF-2341066 对表达 c-Met 活化环突变体 Y1230C 和 Y1235D 的细胞的效力发生明显变化,IC50 分别为 127 nM 和 92 nM。 PF-2341066 还能有效阻止 NCI-H69 和 HOP92 细胞中 c-Met 的磷酸化,IC50 分别为 13 nM 和 16 nM,这些细胞分别表达内源性 c-Met 变体 R988C 和 T1010I[1]
    PF-2341066 还能有效抑制 Karpas299 或 SU-DHL-1 ALCL 细胞中的 NPM-ALK 磷酸化,IC50 为 24 nM。 PF-2341066 可有效阻止细胞增殖,这与 G(1)-S 期细胞周期停滞和诱导 ALK 阳性 ALCL 细胞凋亡有关,IC50 为 30 nM,但对 ALK 阴性淋巴瘤细胞则无此作用[2]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    体内研究
    (In Vivo)

    PF-2341066 在 50 mg/kg/day 和 75 mg/kg/day 治疗组中均能显著消退已形成的大型肿瘤 (> 600 mm),在 GTL-16 模型中,43 天的给药方案使平均肿瘤体积缩小 60%3
    在另一项研究中,PF-2341066 显示出完全抑制 GTL-16 肿瘤生长超过 3 个月的能力,在 50 mg/kg/day 的 3 个月治疗方案中,12 只小鼠中仅有 1 只出现肿瘤生长显著增加。在 GTL-16 肿瘤中,在 12.5 mg/kg/day、25 mg/kg/day 和 50 mg/kg/day 剂量下均观察到 CD31 阳性内皮细胞显著剂量依赖性减少,表明 MVD 抑制与抗肿瘤功效呈剂量依赖性相关性。 PF-2341066 在 GTL-16 和 U87MG 模型中均显示出显著剂量依赖性降低人血浆 VEGFA 和 IL-8 水平。口服 PF-2341066 后,在 GTL-16 肿瘤中观察到磷酸化的 c-Met、Akt、Erk、PLCλ1 和 STAT5 水平显著抑制[1]
    用 50 mg/kg PF-2341066 治疗 c-MET 扩增的 GTL-16 异种移植瘤可引起肿瘤消退,这与 18F-FDG 摄取缓慢减少有关,并降低葡萄糖转运蛋白 1,即 GLUT-1 的表达[4]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    分子量

    486.80

    同用名

    PF-02341066 hydrochloride

    Formula

    C21H23Cl3FN5O

    CAS 号
    性状

    固体

    颜色

    Yellow to brown

    中文名称

    克里唑替尼盐酸

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    4°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    溶解性数据
    细胞实验: 

    H2O 中的溶解度 : 50 mg/mL (102.71 mM; 超声助溶)

    DMSO 中的溶解度 : ≥ 4.9 mg/mL (10.07 mM; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

    * "≥" means soluble, but saturation unknown.

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 2.0542 mL 10.2712 mL 20.5423 mL
    5 mM 0.4108 mL 2.0542 mL 4.1085 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    * 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物实验:

    以下溶解方案,请直接配制工作液。建议现用现配,在短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比; 如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。

    • 方案 一

      请依序添加每种溶剂: PBS

      Solubility: 55 mg/mL (112.98 mM); 澄清溶液; 超声助溶

    动物溶解方案计算器
    请输入动物实验的基本信息:

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    由于实验过程有损耗,建议您多配一只动物的量
    计算结果
    工作液所需浓度 : mg/mL
    该产品水溶性佳,请具体参考实测 水 / PBS / Saline 中的溶解度数据。
    您所需的储备液浓度超过该产品的实测溶解度,如有需要,请与 MCE 中国技术支持联系。
    纯度 & 产品资料

    纯度: 99.86%

    参考文献
    Cell Assay
    [1]

    Tumor cells are seeded in 96-well plates at low density in media supplemented with 10% FBS (growth media) and transferred to serum-free media (0% FBS and 0.04% BSA) after 24 h. Appropriate controls or designated concentrations of PF-2341066 are added to each well, and cells are incubated for 24 to 72 h. Human umbilical vascular endothelial cells (HUVEC) are seeded in 96-well plates in EGM2 media for 5 to 6 h at > 20,000 cells per well and transferred to serum-free media overnight. The following day, appropriate controls or designated concentrations of PF-2341066 are added to each well, and after 1 h incubation, HGF is added to designated wells at 100 ng/mL. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay is done to determine the relative tumor cell or HUVEC numbers.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [1]

    Athymic mice bearing xenografts (300-800 mm3) are given PF-2341066 in water by oral gavage at designated dose levels. At designated times following PF-2341066 administration, mice are humanely euthanized, and tumors are resected. Tumors are snap frozen and pulverized using a liquid nitrogen-cooled cryomortar and pestle, protein lysates are generated, and protein concentrations are determined using a BSA assay. The level of total and phosphorylated protein is determined using a capture ELISA or immunoprecipitation-immunoblotting method.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    参考文献

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    DMSO / H2O 1 mM 2.0542 mL 10.2712 mL 20.5423 mL 51.3558 mL
    5 mM 0.4108 mL 2.0542 mL 4.1085 mL 10.2712 mL
    10 mM 0.2054 mL 1.0271 mL 2.0542 mL 5.1356 mL
    H2O 15 mM 0.1369 mL 0.6847 mL 1.3695 mL 3.4237 mL
    20 mM 0.1027 mL 0.5136 mL 1.0271 mL 2.5678 mL
    25 mM 0.0822 mL 0.4108 mL 0.8217 mL 2.0542 mL
    30 mM 0.0685 mL 0.3424 mL 0.6847 mL 1.7119 mL
    40 mM 0.0514 mL 0.2568 mL 0.5136 mL 1.2839 mL
    50 mM 0.0411 mL 0.2054 mL 0.4108 mL 1.0271 mL
    60 mM 0.0342 mL 0.1712 mL 0.3424 mL 0.8559 mL
    80 mM 0.0257 mL 0.1284 mL 0.2568 mL 0.6419 mL
    100 mM 0.0205 mL 0.1027 mL 0.2054 mL 0.5136 mL

    * 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    Crizotinib hydrochloride
    目录号:
    HY-50878A
    需求量: